ACCELERATING CYTOKINE DRUG DISCOVERY AND QC LOT RELEASE TESTING WITH QUALIFIED, FUNCTIONAL CELL-BASED ASSAYS
Cytokines and their receptors have emerged as major drug targets for inflammatory and autoimmune diseases, allergies, and, more recently, in cancer immunotherapies... Read More
EMPLOYING KILR CYTOTOXICITY READY-TO-USE BIOASSAYS FROM SCREENING TO LOT-RELEASE APPLICATIONS
Webinar Highlights and Q&A Webinar: Cytotoxicity Bioassays – Measuring Antibody-Mediated Direct Cell Death (watch webinar) Therapeutic antibodies that can elicit different applications... Read More
Unlocking Orphan GPCRs with an Innovative Forward Trafficking Approach
Application of GPCR Pharmacotrafficking & Cell-Based Assays Orphan G Protein-Coupled Receptors (oGPCRs) comprise one-third of the druggable GPCR space1. Despite their pharmacotherapeutic... Read More
USE OF AUTOMATED FUNCTIONAL, CELL-BASED BIOASSAYS
Importance in Drug Discovery & Development for Quality Testing Programs Cell-based assays have emerged as crucial tools for basic and applied research.... Read More